Analysis of adiponectin levels revealed a threefold increase in participants with AD compared to the control group (19.1 vs. 6.2 μg/ml respectively, p < 0.001) (Table 2, Fig. 1). This evidence concerns the gene ADIPOQ and Alzheimer disease.